α-SMA, an activation marker of hepatic stellate cells, is overexpressed in NASH which was partly reversed by OCA, but the relative expression of ACTA2 is not altered by OCA. This evidence concerns the gene ACTA2 and metabolic dysfunction-associated steatohepatitis.